MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

April 27, 2018

The Office of the United States Trade Representative (USTR) released its annual “Special 301 Report” today, which reviews countries based on their intellectual property (IP) rights protection and enforcement. Countries that are deemed by the U.S. to not protect IP strongly enough are placed on this watch list.

April 25, 2018

Malaria is one of the leading killers of young children worldwide, even though it is both preventable and easily cured. Doctors Without Borders/Médecins Sans Frontières (MSF) treated 2.5 million people for malaria in 2017.

Malaria tends to come in waves, seasonally, or at specific times of the year in zones where it is endemic. At any given time of year, there is a “malaria peak” somewhere in the world. We know that malaria season will come, and we know that it will cause the deaths of thousands of children.

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

January 30, 2018

Mit Philips, a health policy adviser at Doctors Without Borders/Médecins Sans Frontières (MSF), discusses the ongoing challenges left behind by the Ebola outbreaks in West Africa. View External Media.

December 01, 2017

Only 1 in 4 people living with HIV are receiving treatment in Guinea; without treatment, they can easily develop AIDS. Doctors Without Borders/Médecins Sans Frontières (MSF) supports a hospital in Conakry, Guinea, that treats those who have developed AIDS. Patients arrive very ill, often with opportunistic infections.

November 20, 2017

Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine Prevnar13 (PCV13), said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act.

October 13, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières(MSF) filed a petition before the High Court of Delhi today to overturn a patent granted to Pfizer pharmaceutical corporation on the pneumococcal conjugate vaccine (PCV).

August 22, 2017

Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

Pages

April 27, 2018

The Office of the United States Trade Representative (USTR) released its annual “Special 301 Report” today, which reviews countries based on their intellectual property (IP) rights protection and enforcement. Countries that are deemed by the U.S. to not protect IP strongly enough are placed on this watch list.

April 25, 2018

Malaria is one of the leading killers of young children worldwide, even though it is both preventable and easily cured. Doctors Without Borders/Médecins Sans Frontières (MSF) treated 2.5 million people for malaria in 2017.

Malaria tends to come in waves, seasonally, or at specific times of the year in zones where it is endemic. At any given time of year, there is a “malaria peak” somewhere in the world. We know that malaria season will come, and we know that it will cause the deaths of thousands of children.

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

January 30, 2018

Mit Philips, a health policy adviser at Doctors Without Borders/Médecins Sans Frontières (MSF), discusses the ongoing challenges left behind by the Ebola outbreaks in West Africa. View External Media.

December 01, 2017

Only 1 in 4 people living with HIV are receiving treatment in Guinea; without treatment, they can easily develop AIDS. Doctors Without Borders/Médecins Sans Frontières (MSF) supports a hospital in Conakry, Guinea, that treats those who have developed AIDS. Patients arrive very ill, often with opportunistic infections.

November 20, 2017

Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine Prevnar13 (PCV13), said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act.

October 13, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières(MSF) filed a petition before the High Court of Delhi today to overturn a patent granted to Pfizer pharmaceutical corporation on the pneumococcal conjugate vaccine (PCV).

August 22, 2017

Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

Pages